38932-40-0
Chemical Structure
Cephalexin sodium
- CAS No.: 38932-40-0
- Formula:C16H16N3NaO4S
- Molecular Weight:369.37
IUPAC Name: (6R,7R)-7-((R)-2-amino-2-phenylacetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, sodium salt
InChIKey: NZDYPHVJLWMLJI-CYJZLJNKSA-M
SMILES: O=C1N2[C@@](SCC(C)=C2C(O[Na])=O)([H])[C@@H]1NC([C@@H](C3=CC=CC=C3)N)=O
Biological Activity: Cephalexin sodium is an orally active cephalosporin Antibiotic. Cephalexin sodium disrupts bacterial cell wall synthesis and inhibits the growth of susceptible Gram-positive bacteria and some Gram-negative bacteria. Cephalexin sodium induces acute renal failure when overdosed in laboratory animals. Cephalexin sodium can be used in studies related to bacterial infections[1][2][3][4].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cephalexin sodium | Cephalexin sodium is an orally active cephalosporin Antibiotic. Cephalexin sodium disrupts bacterial cell wall synthesis and inhibits the growth of susceptible Gram-positive bacteria and some Gram-negative bacteria. Cephalexin sodium induces acute renal failure when overdosed in laboratory animals. Cephalexin sodium can be used in studies related to bacterial infections. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Jawad A M, et al. Innovation, preparation of cephalexin drug derivatives and studying of (toxicity & resistance of infection)[J]. International Journal of Psychosocial Rehabilitation, 2020, 24(04): 3754-3767.
- [2]. Benarab N, et al. The issues of antibiotics: cephalexin antibiotic as emerging environment contaminant[J]. Int. J. Sci. Res. Publ, 2020, 10(2): 306-318.
- [3]. Wick WE. Cephalexin, a new orally absorbed cephalosporin antibiotic. Applied microbiology. 1967 Jul;15(4):765-9. [Content Brief]
- [4]. Lode H, et al. Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000. Antimicrobial agents and chemotherapy. 1979 Jul;16(1):1-6. [Content Brief]
Keywords
